MedPath

HEalthy Living in Inflammatory Arthritis (HELIA trial): a randomized controlled trial comparing efficacy between an interactive, online lifestyle intervention program and general nutrition recommendations

Phase 4
Recruiting
Conditions
Inflammatory arthritis
(symmetrical) joint inflammation with or without antibodies
10013361
Registration Number
NL-OMON51687
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

In order to be eligible to participate in the study, a subject must meet all of
the following criteria:
- Diagnosed with rheumatoid arthritis(RA) or psoriatic arthritis(PsA),
according to respectively the ACR/EULAR 2010 criteria for RA and CASPAR criteria
- Low disease activity, defined as Disease Activity Score (DAS28)<3.5 and >2.6
or Disease Activity in PSoriatic Arthritis(DAPSA) <16 and >5
- Stable DMARD dosage in the past six months
- Age >=18 years;

Exclusion Criteria

- Unable to understand, speak and write in Dutch

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath